| Staying hepatitis C negative: a systematic review and meta‐analysis of cure and reinfection in people who inject drugs NH Latham, JS Doyle, AY Palmer, JW Vanhommerig, P Agius, ... Liver International 39 (12), 2244-2260, 2019 | 50 | 2019 |
| “I'm obviously not dying so it's not something I need to sort out today”: Considering hepatitis C treatment in the era of direct acting antivirals C Wright, S Cogger, K Hsieh, S Goutzamanis, M Hellard, P Higgs Infection, disease & health 24 (2), 58-66, 2019 | 31 | 2019 |
| Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study S Goutzamanis, JS Doyle, A Thompson, P Dietze, M Hellard, P Higgs, ... BMC Infectious Diseases 18, 1-8, 2018 | 18 | 2018 |
| Improving hepatitis C direct‐acting antiviral access and uptake: A role for patient‐reported outcomes and lived experience S Goutzamanis, J Doyle, P Higgs, M Hellard Journal of Viral Hepatitis 26 (2), 218-223, 2019 | 14 | 2019 |
| Peer to peer communication about hepatitis C treatment amongst people who inject drugs: A longitudinal qualitative study S Goutzamanis, JS Doyle, D Horyniak, P Higgs, M Hellard, ... International Journal of Drug Policy 87, 102983, 2021 | 9 | 2021 |
| Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure M Stoové, J Wallace, P Higgs, A Pedrana, S Goutzamanis, N Latham, ... The International journal on drug policy 75, 102596, 2020 | 8 | 2020 |
| Patient‐reported outcomes of the Treatment and Prevention Study: A real‐world community‐based trial of direct‐acting antivirals for hepatitis C among people who inject drugs S Goutzamanis, T Spelman, B Harney, P Dietze, M Stoove, P Higgs, ... Journal of viral hepatitis 28 (7), 1068-1077, 2021 | 7 | 2021 |
| Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: A qualitative study S Goutzamanis, D Horyniak, JS Doyle, M Hellard, P Higgs, ... Harm Reduction Journal 18, 1-6, 2021 | 6 | 2021 |
| Stigma Associated with Alcohol and Other Drug Use Among People from Migrant and Ethnic Minority Groups: Results from a Systematic Review of Qualitative Studies CH Douglass, TM Win, S Goutzamanis, MSC Lim, K Block, G Onsando, ... Journal of Immigrant and Minority Health 25 (6), 1402-1425, 2023 | 4 | 2023 |
| Direct-acting antiviral treatment for HCV S Goutzamanis, J Doyle, A Thompson, M Hellard, P Higgs The Lancet Infectious Diseases 16 (12), 1325-1326, 2016 | 4 | 2016 |
| Increasing amphetamine use and forensic involvement among clients of three residential Indigenous alcohol and other drug services in Victoria, Australia S Goutzamanis, P Higgs, M Richardson, S MacLean Drug and Alcohol Review 37 (5), 671-675, 2018 | 3 | 2018 |
| P17 The impact of hepatitis C-related uncertainty on self-reported stress in people who inject drugs living with hepatitis C S Goutzamanis, JS Doyle, A Thompson, P Dietze, M Hellard, P Higgs | 1 | 2017 |
| Exploring opportunities for hepatitis C treatment uptake among people who inject drugs in Australia: a qualitative study P Aung, S Goutzamanis, C Douglass, M Stoove, M Hellard, P Dietze, ... Journal of Substance Use, 1-6, 2023 | | 2023 |
| “Like a pickle that’s been unpickled”: Emotional, identity and behavioural transformations throughout hepatitis C treatment S Goutzamanis, JS Doyle, D Horyniak, P Higgs, M Hellard Plos one 17 (12), e0272401, 2022 | | 2022 |
| The impact of curative hepatitis C treatment on the health and wellbeing of people who inject drugs. S GOUTZAMANIS Monash University, 2020 | | 2020 |
| Reducing alcohol-related harm in people recently treated for hepatitis C S Hermosa, S Goutzamanis, J Doyle, P Higgs Australian Journal of Primary Health 25 (3), 193, 2019 | | 2019 |
| Changes in attitudes, knowledge and everyday life throughout direct-acting antiviral treatment for hepatitis C: a longitudinal qualitative study S Goutzamanis, P Higgs, J Doyle, M Hellard | | |
